Patents by Inventor Amy M. Delaney

Amy M. Delaney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleic acids encoding cytosine deaminase
    Patent number: 7556955
    Abstract: A new cytosine deaminase gene and protein from Candida kefyr are provided. This protein has increased ability to convert the 5-fluorocytosine prodrug to its toxic form when compared against the E. coli enzyme.
    Type: Grant
    Filed: July 20, 2006
    Date of Patent: July 7, 2009
    Assignee: Onyx Pharmaceuticals, Inc.
    Inventors: Yuqiao Shen, Sylvie Laquerre, Amy M. Delaney, Charles A. Omer
  • Antibody that specifically binds to Cytosine deaminase
    Patent number: 7414113
    Abstract: A new cytosine deaminase gene and protein from Candida kefyr are provided. This protein has increased ability to convert the 5-fluorocytosine prodrug to its toxic form when compared against the E. coli enzyme.
    Type: Grant
    Filed: July 20, 2006
    Date of Patent: August 19, 2008
    Assignee: Onyx Pharmaceuticals, Inc.
    Inventors: Yuqiao Shen, Sylvie Laquerre, Amy M. Delaney, Charles A. Omer
  • cytosine deaminase
    Patent number: 7141404
    Abstract: A new cytosine deaminase gene and protein from Candida kefyr are provided. This protein has increased ability to convert the 5-fluorocytosine prodrug to its toxic form when compared against the E. coli enzyme.
    Type: Grant
    Filed: December 22, 2003
    Date of Patent: November 28, 2006
    Assignee: Onyx Pharmaceuticals, Inc.
    Inventors: Yuqiao Shen, Sylvie Laquerre, Amy M. Delaney, Charles A. Omer
  • Candida kefyr cytosine deaminase
    Publication number: 20040180418
    Abstract: A new cytosine deaminase gene and protein from Candida kefyr are provided. This protein has increased ability to convert the 5-fluorocytosine prodrug to its toxic form when compared against the E. coli enzyme.
    Type: Application
    Filed: December 22, 2003
    Publication date: September 16, 2004
    Applicant: Onyx Pharmaceuticals, Inc.
    Inventors: Yuqiao Shen, Sylvie Laquerre, Charles A. Omer, Amy M. Delaney